Cardiac sodium channel Nav1.5 and interacting proteins: Physiology and pathophysiology

被引:187
作者
Abriel, Hugues [1 ]
机构
[1] Univ Bern, Dept Clin Res, CH-3010 Bern, Switzerland
基金
瑞士国家科学基金会;
关键词
LONG-QT SYNDROME; INFANT-DEATH-SYNDROME; CALMODULIN KINASE-II; NA+ CHANNEL; BRUGADA-SYNDROME; MOLECULAR DETERMINANTS; DILATED CARDIOMYOPATHY; INTRACELLULAR CALCIUM; EXTRACELLULAR DOMAIN; CONDUCTION DISORDER;
D O I
10.1016/j.yjmcc.2009.08.025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The cardiac voltage-gated Na+ channel Na(v)1.5 generates the cardiac Na+ current (INa). Mutations in SCN5A, the gene encoding Na(v)1.5, have been linked to many cardiac phenotypes, including the congenital and acquired long QT syndrome, Brugada syndrome, conduction slowing, sick sinus syndrome, atrial fibrillation, and dilated cardiomyopathy. The mutations in SCN5A define a sub-group of Na(v)1.5/SCN5A-related phenotypes among cardiac genetic channelopathies. Several research groups have proposed that Na(v)1.5 may be part of multi-protein complexes composed of Na(v)1.5-interacting proteins which regulate channel expression and function. The genes encoding these regulatory proteins have also been found to be mutated in patients with inherited forms of cardiac arrhythmias. The proteins that associate with Na(v)1.5 may be classified as (1) anchoring/adaptor proteins, (2) enzymes interacting with and modifying the channel, and (3) proteins modulating the biophysical properties of Na(v)1.5 upon binding. The aim of this article is to review these Na(v)1.5 partner proteins and to discuss how they may regulate the channel's biology and function. These recent investigations have revealed that the expression level, cellular localization, and activity of Na(v)1.5 are finely regulated by complex molecular and cellular mechanisms that we are only beginning to understand. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:2 / 11
页数:10
相关论文
共 50 条
[41]   Local-anesthetic like inhibition of the cardiac sodium channel Nav1.5 α-subunit by 5-HT3 receptor antagonists [J].
van't Klooster, Mariet P. ;
Foadi, Nilufar ;
Hage, Axel ;
Stoetzer, Carsten ;
Wegner, Florian ;
Eberhardt, Mirjam ;
Leffler, Andreas .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2016, 789 :119-126
[42]   Supramolecular clustering of the cardiac sodium channel Nav1.5 in HEK293F cells, with and without the auxiliary β3-subunit [J].
Salvage, Samantha C. ;
Rees, Johanna S. ;
McStea, Alexandra ;
Hirsch, Michael ;
Wang, Lin ;
Tynan, Christopher J. ;
Reed, Matthew W. ;
Irons, Jennifer R. ;
Butler, Richard ;
Thompson, Andrew J. ;
Martin-Fernandez, Marisa L. ;
Huang, Christopher L-H ;
Jackson, Antony P. .
FASEB JOURNAL, 2020, 34 (03) :3537-3553
[43]   A New Cardiac Channelopathy: From Clinical Phenotypes to Molecular Mechanisms Associated With Nav1.5 Gating Pores [J].
Moreau, Adrien ;
Chahine, Mohamed .
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2018, 5
[44]   KV4.3 Expression Modulates NaV1.5 Sodium Current [J].
Portero, Vincent ;
Wilders, Ronald ;
Casini, Simona ;
Charpentier, Flavien ;
Verkerk, Arie O. ;
Remme, Carol Ann .
FRONTIERS IN PHYSIOLOGY, 2018, 9
[45]   Infant sudden death: Mutations responsible for impaired Nav1.5 channel trafficking and function [J].
Gando, Ivan ;
Morganstein, Jace ;
Jana, Kundan ;
McDonald, Thomas V. ;
Tang, Yingying ;
Coetzee, William A. .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2017, 40 (06) :703-712
[46]   Inhibition of human Nav1.5 sodium channels by strychnine and its analogs [J].
Yuan, Chunhua ;
Sun, Lirong ;
Zhang, Meng ;
Li, Shuji ;
Wang, Xuemin ;
Gao, Tianming ;
Zhu, Xinhong .
BIOCHEMICAL PHARMACOLOGY, 2011, 82 (04) :350-357
[47]   The Beta1-subunit of Nav1.5 cardiac sodium channel is required for a dominant negative effect through alpha-alpha interaction [J].
Mercier, A. ;
Clement, R. ;
Harnois, T. ;
Bourmeyster, N. ;
Faivre, J. F. ;
Findlay, I. ;
Chahine, M. ;
Bois, P. ;
Chatelier, A. .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 :81-81
[48]   Calcium-dependent Nedd4-2 upregulation mediates degradation of the cardiac sodium channel Nav1.5: implications for heart failure [J].
Luo, L. ;
Ning, F. ;
Du, Y. ;
Song, B. ;
Yang, D. ;
Salvage, S. C. ;
Wang, Y. ;
Fraser, J. A. ;
Zhang, S. ;
Ma, A. ;
Wang, T. .
ACTA PHYSIOLOGICA, 2017, 221 (01) :44-58
[49]   Characterization of a novel Nav1.5 channel mutation, A551T, associated with Brugada syndrome [J].
Chiang, Kun-Chi ;
Lai, Ling-Ping ;
Shieh, Ru-Chi .
JOURNAL OF BIOMEDICAL SCIENCE, 2009, 16
[50]   Proteasome nhibitor (MG 132) rescues Nav1.5 protein content and the cardiac sodium current in dystrophin-deficient mdx5cv mice [J].
Rougier, Jean-Sebastien ;
Gavillet, Bruno ;
Abriel, Hugues .
FRONTIERS IN PHYSIOLOGY, 2013, 4